Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Hepatitis C Market Valuation Change Between Now And 2029?

The Hepatitis C market has seen a considerable expansion in the recent past. The projected growth is from $67.17 billion in 2024 to an impressive $75.72 billion in 2025, yielding a compound annual growth rate (CAGR) of 12.7%. This substantial progress can be attributed to factors such as blood transfusion procedures, use of injection drugs, limited therapeutic alternatives, and the breakthrough in the development of Direct-Acting Antivirals (DAA’s).

The market size for hepatitis C is anticipated to witness a significant upsurge in the upcoming years. The projected growth is set to reach $132.21 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.0%. This impending growth during the forecasted period could be due to intensified worldwide eradication initiatives, enhanced testing and screening processes, increased expenditure in healthcare, incorporation of telemedicine, and the inception of upcoming therapeutic combinations. Key trends for the period forecasted encompass available and cost-effective treatment, attention to high-risk demographics, progress in drug formulations, combined efforts and collaborations, and the rise of telehealth and digital solutions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

What Underlying Factors Are Supporting The Hepatitis C Market Growth?

The rise in viral infections is projected to stimulate the growth of the hepatitis C market. The term viral infections pertains to those caused by a virus within the body. The treatment for Hepatitis C helps in reducing these viral infections by eradicating them and reviving the immune response in hepatitis C patients post viral clearance. For example, as per the Centers for Disease Control and Prevention, a public health agency in the U.S., there was a significant increase in the percentage of individuals suffering from Parvovirus B19, a seasonal respiratory viral infection, in all age groups – the figures rose from 3% during 2022–2024 to 10% by June 2024; the most notable increase was seen in children aged 5–9 years, as the prevalence surged from 15% between 2022–2024 to 40% by June 2024. Additionally, the fraction of pooled samples that contained parvovirus B19 DNA levels witnessed a significant rise, ballooning from 1.5% in December 2023 to 19.9% by June 2024. This rise in viral infections is thereby fueling the growth of the hepatitis C market.

Which Sub-Segments Are Driving Growth Within The Hepatitis C Market?

The hepatitis cmarket covered in this report is segmented –

1) By Type: Chronic Hepatitis C; Acute Hepatitis C; Other Types

2) By Treatment: Antiviral Drugs; Vaccine; Immune Modulator Drugs; Surgery; Other Treatments

3) By Diagnosis: Liver Biopsy; Blood Tests; Imaging Tests; Other Diagnosis

4) By Distribution Channel: Hospital And Retail Pharmacies; Online Pharmacies

5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Diagnostic Laboratories; Research Institutes; Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1; Genotype 2; Genotype 3; Genotype 4; Genotype 5; Genotype 6

2) By Acute Hepatitis C: Symptomatic; Asymptomatic

3) By Other Types: Mixed Infections; Superinfection

What Current And Upcoming Trends Are Shaping The Hepatitis C Market?

One trend gaining traction in the hepatitis C market is the development of advanced diagnostic technologies for hepatitis C. To maintain a competitive edge in the market, top-notch enterprises in the hepatitis C segment are embracing innovative technologies. The Swiss pharmaceutical and diagnostics company, F. Hoffmann-La Roche Ltd., exhibited this trend in July 2022 when it unveiled the Elecsys HCV Duo immunoassay in countries recognizing the CE Mark. This breakthrough allows the hepatitis C virus (HCV) antigen and antibody status to be ascertained concurrently and separately from a sole human plasma or serum specimen via the immunoassay Elecsys HCV Duo. The test also holds potential in identifying patients who are recovering or show signs of a chronic infection that might lead to additional illnesses like liver cancer and conditions in their early stages.

Which Companies Hold A Competitive Edge In The 281 Market?

Major companies operating in the hepatitis C market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Which Region Dominates The Hepatitis C Market Today?

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp

Browse Through More Reports Similar to the Global Hepatitis C Market 2025, By The Business Research Company

Hepatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

Non Alcoholic Steatohepatitis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model